Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
OTC Naloxone May Get Another Push From US FDA As Agency Prepares Novel Switch Proposed Rule
May 05 2022
•
By
Derrick Gingery
FDA Commissioner Robert Califf said the instructions for use will be important for OTC naloxone products. • Source: Shutterstock
More from R&D
More from Pink Sheet